UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
851
Krystal Biotech
KRYS
$9.79B
| $32.2M | 0.01% |
234,320
-341,186
| -59% | -$50.1M |
2019 Q4
22 quarters
|
|
852
Dropbox
DBX
$7.75B
| $32.2M | 0.01% |
1,124,695
+166,219
| +17% | +$4.71M |
2018 Q4
26 quarters
|
|
853
Knife River
KNF
$2.72B
| $32.2M | 0.01% |
393,969
+166,404
| +73% | +$15.2M |
2023 Q3
7 quarters
|
|
854
Flowserve
FLS
$8.92B
| $32.2M | 0.01% |
614,356
-20,490
| -3% | -$964K |
2013 Q2
48 quarters
|
|
855
Repligen
RGEN
$11.3B
| $32.2M | 0.01% |
258,571
+6,074
| +2% | +$773K |
2014 Q3
43 quarters
|
|
856
Jefferies Financial Group
JEF
$10.1B
| $32.1M | 0.01% |
587,585
+149,746
| +34% | +$7.41M |
2013 Q2
48 quarters
|
|
857
Shift4
FOUR
$3B
| $32.1M | 0.01% |
323,982
+24,244
| +8% | +$2.11M |
2020 Q2
20 quarters
|
|
858
DELISTED
Mr. Cooper
COOP
| $32.1M | 0.01% |
215,112
+78,438
| +57% | +$10.1M |
2023 Q1
9 quarters
|
|
859
MKS Inc
MKSI
$15.9B
| $32M | 0.01% |
321,712
+54,291
| +20% | +$4.41M |
2013 Q2
48 quarters
|
|
860
Medpace
MEDP
$17.2B
| $31.8M | 0.01% |
101,443
+19,626
| +24% | +$5.89M |
2023 Q1
9 quarters
|
|
861
Lamb Weston
LW
$7.31B
| $31.8M | 0.01% |
613,867
+184,704
| +43% | +$9.89M |
2016 Q4
34 quarters
|
|
862
Varonis Systems
VRNS
$5.41B
| $31.8M | 0.01% |
626,732
+7,475
| +1% | +$340K |
2017 Q1
33 quarters
|
|
863
Option Care Health
OPCH
$4.66B
| $31.7M | 0.01% |
975,325
-576,534
| -37% | -$18.6M |
2019 Q4
22 quarters
|
|
864
Bath & Body Works
BBWI
$3.82B
| $31.7M | 0.01% |
1,057,309
+494,552
| +88% | +$14.5M |
2013 Q2
48 quarters
|
|
865
Affiliated Managers Group
AMG
$9.62B
| $31.5M | 0.01% |
160,277
+18,544
| +13% | +$3.22M |
2013 Q2
48 quarters
|
|
866
Highwoods Properties
HIW
$3.14B
| $31.5M | 0.01% |
1,012,324
+867,514
| +599% | +$25.5M |
2013 Q2
48 quarters
|
|
867
Roivant Sciences
ROIV
$24.3B
| $31.3M | 0.01% |
2,775,349
+329,542
| +13% | +$3.57M |
2022 Q2
12 quarters
|
|
868
Ionis Pharmaceuticals
IONS
$7.1B
| $31.3M | 0.01% |
791,072
+131,637
| +20% | +$4.31M |
2013 Q2
48 quarters
|
|
869
Franco-Nevada
FNV
$45.3B
| $31.2M | 0.01% |
190,433
-63,209
| -25% | -$10.5M |
2024 Q2
4 quarters
|
|
870
Five Below
FIVE
$12.1B
| $31.2M | 0.01% |
237,796
+53,278
| +29% | +$5.19M |
2013 Q2
48 quarters
|
|
871
GitLab
GTLB
$8.86B
| $31.2M | 0.01% |
691,342
+105,689
| +18% | +$4.83M |
2022 Q2
12 quarters
|
|
872
UMB Financial
UMBF
$9.79B
| $31.2M | 0.01% |
296,267
+88,386
| +43% | +$8.81M |
2013 Q2
48 quarters
|
|
873
Vivmark Residential
VMRK
$47B
| $31.1M | 0.01% |
461,133
-4,235,042
| -90% | -$291M |
2013 Q2
48 quarters
|
|
874
RLI Corp
RLI
$5.29B
| $31.1M | 0.01% |
430,822
+50,090
| +13% | +$3.76M |
2013 Q2
48 quarters
|
|
875
Talen Energy Corp
TLN
$17B
| $31.1M | 0.01% |
106,844
+57,794
| +118% | +$13.7M |
2024 Q4
2 quarters
|
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.